UK Coronavirus Vaccine Takes Major Step Forward with Mass-Production Plans

Strategic Insights -

The University of Oxford has announced a significant partnership with pharmaceutical giant AstraZeneca to develop, manufacture, and distribute its Covid-19 vaccine candidate, following human trials that began last week. The agreement aims to enable rapid vaccination around the world if the vaccine proves to be effective. The vaccine is being trialled in the UK, with hundreds of people volunteering for the study, which received £20 million in Government funding.

Key Takeaways:

  • The University of Oxford has partnered with AstraZeneca for the development, manufacture, and large-scale distribution of the Covid-19 vaccine candidate.
  • The agreement will allow for rapid vaccination around the world if the candidate proves to be effective.
  • Human trials of the vaccine began last week, with hundreds of people volunteering to be part of the study, which received £20 million in Government funding.
  • The partnership aims to improve the UK's manufacturing capacity for vaccines, which is currently not where it needs to be.
  • Both partners have agreed to operate on a not-for-profit basis for the duration of the pandemic, with only the costs of production and distribution being covered.
  • Professor Sir John Bell hopes that some results from the human trial of the vaccine will be available by mid-June.
  • The vaccine is an adenovirus vaccine vector (ChAdOx1) and was developed at Oxford's Jenner Institute.
  • Phase 1 of the trial will involve 510 healthy participants, aged 18 to 55, who will either receive the vaccine or a control injection for comparison.

Statistics:

  • The vaccine trial received £20 million in Government funding.
  • The partnership with AstraZeneca aims to improve the UK's manufacturing capacity for vaccines, which is currently not where it needs to be.
  • 510 healthy participants will be involved in Phase 1 of the trial.
  • The trial is currently being done on a not-for-profit basis for the duration of the pandemic.

Sources:

  • "University of Oxford and AstraZeneca form major partnership to develop COVID-19 vaccine" (BBC News)
  • "Oxford University's Covid-19 vaccine trial 'in mid-June'" (BBC Radio 4 Today programme)
  • "Coronavirus vaccine: Oxford and AstraZeneca partner on pandemic effort" (The Guardian)